Search / Trial NCT06234644

Effects of Maze Activities in Down's Syndrome

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jan 28, 2024

Trial Information

Current as of December 21, 2024

Completed

Keywords

Down's Syndrome Mobility Standardized Walking Obstacle Course (Swoc).

ClinConnect Summary

This study will be a randomized control trail used to compare the Effects of Maze Activities on Mobility in Children With Down's Syndrome. Subjects with Down's syndrome meeting the predetermined inclusion and exclusion criteria will be divided into two groups using simple random sampling technique. Assessment will be done by using time up and go test and Standardized Walking Obstacle Course (SWOC). Subjects in group A will receive the conventional intervention of gait training and Group B will receive the training on Standardized walking obstacle course.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • •Age 6 to 12 years of downs's syndrome children
  • Ambulatory Child who can walk without any assistive device(6)
  • Should follow commands and can perform 30 sec walk test.(6)
  • Exclusion Criteria:
  • •Any congenital Cardiac Anomaly
  • Visual and Hearing Deficits
  • Any surgical intervention for the last 6 months

Trial Officials

Fibha Tariq, MS*

Principal Investigator

Riphah international university lahore

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0